Cécile Fouret is a trained pharmacist and a graduate of ESC Tours. She began her career at AFSSAPS (now ANSM) and later worked at PAREXEL. For over 20 years at Medtronic, she has held positions including Head of Market Access and Regulatory Affairs, Director of Clinical and Scientific Affairs, and Responsible Pharmacist for the establishment. As part of the Medicen Project Evaluation Committee, she also supports the development of innovative projects.
Medtronic is a global leader in healthcare technology, dedicated to alleviating pain, restoring health, and extending life through innovative medical devices and therapies. Founded in 1949, Medtronic employs over 95,000 people across 150 countries. Their solutions address more than 70 health conditions, treating approximately 74 million patients annually.
In fiscal year 2024, Medtronic achieved around $31 billion in revenue, investing $2.7 billion in R&D, leading to over 43,000 active patents and more than 190 ongoing clinical trials. Headquartered operationally in Minneapolis and legally in Dublin, Ireland, the company continues to pioneer life-changing technologies like pacemakers, insulin pumps, and neuromodulation devices.
